José María
López-Picazo González
Consultor Médico
Luis Alfonso
Gurpide Ayarra
Consultor Médico
Publicaciones en las que colabora con Luis Alfonso Gurpide Ayarra (23)
2020
-
Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients
Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348
2019
2018
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2016
-
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694
2014
-
Erratum to: Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
European Journal of Nuclear Medicine and Molecular Imaging
-
Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma
PLoS ONE, Vol. 9, Núm. 1
-
Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy
PLoS ONE, Vol. 9, Núm. 2
-
Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Núm. 11, pp. 2058-2065
2012
-
The multimodal management of locally advanced N2 non-small cell lung cancer: Is there a role for surgical resection? A single institution's experience
Clinical and Translational Oncology, Vol. 14, Núm. 11, pp. 835-841
2010
2009
-
EUELC project: A multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration
European Respiratory Journal, Vol. 34, Núm. 6, pp. 1477-1486
-
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
British Journal of Cancer, Vol. 100, Núm. 7, pp. 1111-1119
-
Role of surgery in a multidisciplinary approach to superior sulcus tumors (SST): Morbidity and prognostic factors for long-term success after resection
Thoracic and Cardiovascular Surgeon, Vol. 57, Núm. 6, pp. 353-357
2008
-
Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation
Radiotherapy and Oncology, Vol. 88, Núm. 3, pp. 342-350
2007
-
Carcinoma microcítico de pulmón
Revista de medicina, Vol. 51, Núm. 2, pp. 7-13
-
Nuevos tratamientos para el carcinoma renal
Anales del sistema sanitario de Navarra, Vol. 30, Núm. 3, pp. 393-403
-
Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy
Oncologist, Vol. 12, Núm. 9, pp. 1151-1155
-
Small-cell lung cancer
Revista de medicina de la Universidad de Navarra, Vol. 51, Núm. 2, pp. 7-13
2005
-
Activity of gefitinib in central nervous system metastases in patients with non-small-cell lung center: Two case reports and a review of the literature
Clinical Lung Cancer, Vol. 7, Núm. 2, pp. 138-140
-
Assessment of the value of confirming responses in clinical trials in oncology
European Journal of Cancer, Vol. 41, Núm. 11, pp. 1528-1532